Development and validation of a predictive model for estimating EGFR mutation probabilities in patients with non-squamous non-small cell lung cancer in New Zealand

Podobne knjige/članki

• Population-based incidence rates and increased risk of EGFR mutated non-small cell lung cancer in Māori and Pacifica in New Zealand
  od: Aye, Phyu Sin, et al.
  Izdano: (2021)
• Increasing Disadvantages in Cancer Survival in New Zealand Compared to Australia, between 2000-05 and 2006-10
  od: Elwood, J. Mark, et al.
  Izdano: (2016)
• Use of Non-Cancer Medications in New Zealand Women at the Diagnosis of Primary Invasive Breast Cancer: Prevalence, Associated Factors and Effects on Survival
  od: Aye, Phyu Sin, et al.
  Izdano: (2020)
• Lung cancer mutation testing: a clinical retesting study of agreement between a real-time PCR and a mass spectrometry test
  od: Shepherd, Phillip, et al.
  Izdano: (2017)
• Comparative outcomes of squamous and non-squamous non-small cell lung cancer (NSCLC) patients in phase II studies of ASA404 (DMXAA) – retrospective analysis of pooled data
  od: McKeage, Mark J, et al.
  Izdano: (2010)